DKB 19002
Alternative Names: DKB-19002Latest Information Update: 21 Dec 2021
At a glance
- Originator DongKoo Bio&Pharma
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Diabetes mellitus